Notice of Annual General Meeting 2018

Oslo, Norway 8 May 2018 – The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2018 at Oslo Cancer Cluster Innovation Park.

Time: Tuesday May 29, 10am CEST (local time).
Venue: Jónas Einarsson Auditorium (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway.

Please find attached Notice of the Annual General Meeting including attendance and proxy forms, executive remuneration statement, proposed updated articles of associations and the recommendation from the Nomination Committee.

The notice including attendance and proxy forms will be mailed to all shareholders with known address. The complete notice is available at PCI Biotech’s corporate website www.pcibiotech.com.

For further information, please contact:
Ronny Skuggedal, CFO E-mail: rs@pcibiotech.no
Office: +47 67 11 54 00 Mobile: +47 94 00 57 57

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

PCI Biotech Notice of AGM 2018
PCI Biotech Executive remuneration statement
PCI Biotech proposed amendment to Articles of Association
PCI Biotech Proposal from the Nomination Committee